
Tainwala Chemicals (TAINWALCHM) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
53.1M
Gross Profit
10.4M
19.51%
Operating Income
4.5M
8.51%
Net Income
5.5M
10.39%
Balance Sheet Metrics
Total Assets
1.7B
Total Liabilities
135.3M
Shareholders Equity
1.5B
Debt to Equity
0.09
Cash Flow Metrics
Revenue & Profitability Trend
Tainwala Chemicals Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 164.2M | 180.3M | 128.3M | 77.2M | 64.7M |
Cost of Goods Sold | 128.6M | 160.4M | 121.2M | 59.3M | 57.1M |
Gross Profit | 35.5M | 19.9M | 7.1M | 17.9M | 7.6M |
Gross Margin % | 21.7% | 11.0% | 5.6% | 23.2% | 11.7% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 5.8M | 5.2M | 3.6M | 3.0M |
Other Operating Expenses | 13.3M | 4.9M | 6.7M | 27.1M | 5.5M |
Total Operating Expenses | 13.3M | 10.7M | 11.9M | 30.7M | 8.4M |
Operating Income | 8.9M | -6.5M | -23.1M | -39.3M | -27.2M |
Operating Margin % | 5.5% | -3.6% | -18.0% | -50.9% | -42.0% |
Non-Operating Items | |||||
Interest Income | - | 51.2M | 10.5M | 7.3M | 13.2M |
Interest Expense | 141.0K | 113.0K | 103.0K | 3.5M | 399.0K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 62.8M | 55.4M | 38.9M | 3.7M | -3.2M |
Income Tax | 13.6M | 7.2M | 6.1M | 0 | 0 |
Effective Tax Rate % | 21.7% | 13.1% | 15.6% | 0.0% | 0.0% |
Net Income | 49.2M | 48.1M | 32.8M | 3.7M | -3.2M |
Net Margin % | 30.0% | 26.7% | 25.6% | 4.8% | -5.0% |
Key Metrics | |||||
EBITDA | 66.8M | 54.8M | 60.6M | -24.6M | -7.9M |
EPS (Basic) | ₹5.25 | ₹5.14 | ₹3.50 | ₹0.39 | ₹-0.35 |
EPS (Diluted) | ₹5.25 | ₹5.14 | ₹3.50 | ₹0.39 | ₹-0.35 |
Basic Shares Outstanding | 9370476 | 9364000 | 9364000 | 9363863 | 9364000 |
Diluted Shares Outstanding | 9370476 | 9364000 | 9364000 | 9363863 | 9364000 |
Income Statement Trend
Tainwala Chemicals Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 13.9M | 2.9M | 4.0M | 5.0M | 6.2M |
Short-term Investments | 2.9M | 2.3M | 4.5M | 3.8M | 3.3M |
Accounts Receivable | 10.7M | 4.1M | 6.4M | 5.2M | 24.0M |
Inventory | 15.0M | 14.4M | 24.1M | 36.9M | 40.6M |
Other Current Assets | 3.1M | 4.4M | -1.0K | -1.0K | -35.0K |
Total Current Assets | 45.6M | 28.1M | 44.1M | 56.1M | 81.9M |
Non-Current Assets | |||||
Property, Plant & Equipment | - | 1.1M | 1.1M | 1.1M | - |
Goodwill | - | 30.0K | 47.0K | 0 | 0 |
Intangible Assets | - | 30.0K | 47.0K | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 197.0K | 1.0K | 1.0K | 7.3M | 8.1M |
Total Non-Current Assets | 1.6B | 1.2B | 950.3M | 859.4M | 921.2M |
Total Assets | 1.7B | 1.2B | 994.4M | 915.5M | 1.0B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 784.0K | 1.0M | 1.5M | 2.9M | 14.1M |
Short-term Debt | 0 | 0 | - | - | 0 |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 1.2M | 466.0K | 121.0K | 135.0K | 794.0K |
Total Current Liabilities | 3.1M | 2.5M | 2.8M | 7.3M | 18.1M |
Non-Current Liabilities | |||||
Long-term Debt | - | - | - | - | - |
Deferred Tax Liabilities | 128.4M | 49.2M | 0 | - | - |
Other Non-Current Liabilities | - | -1.0K | -1.0K | -2.0K | -1.0K |
Total Non-Current Liabilities | 132.2M | 54.0M | 4.4M | 5.7M | 5.4M |
Total Liabilities | 135.3M | 56.6M | 7.2M | 13.0M | 23.6M |
Equity | |||||
Common Stock | 93.6M | 93.6M | 93.6M | 93.6M | 93.6M |
Retained Earnings | - | 351.6M | 303.4M | 270.6M | 266.9M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.5B | 1.2B | 987.2M | 902.5M | 979.5M |
Key Metrics | |||||
Total Debt | 0 | 0 | 0 | 0 | 0 |
Working Capital | 42.5M | 25.6M | 41.3M | 48.8M | 63.7M |
Balance Sheet Composition
Tainwala Chemicals Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 62.8M | 55.4M | 38.9M | 3.7M | -3.2M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 6.0M | 24.3M | -28.8M | 12.2M | 64.9M |
Operating Cash Flow | 68.9M | 79.8M | 10.2M | 19.4M | 62.1M |
Investing Activities | |||||
Capital Expenditures | -29.0K | 1.2M | -10.8M | -6.0M | -4.9M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | -71.3M | 0 | -42.2M |
Investment Sales | - | - | 0 | 20.1M | - |
Investing Cash Flow | -29.0K | 1.2M | -82.2M | 14.1M | -47.1M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | -28.0K | 0 |
Financing Cash Flow | - | - | - | -56.0K | 0 |
Free Cash Flow | 94.1M | 8.4M | -66.3M | -26.9M | 31.7M |
Net Change in Cash | 68.9M | 81.1M | -72.0M | 33.4M | 15.0M |
Cash Flow Trend
Tainwala Chemicals Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
42.86
Price to Book
1.37
Price to Sales
13.24
PEG Ratio
20.03
Profitability Ratios
Profit Margin
43.72%
Operating Margin
-12.29%
Return on Equity
3.20%
Return on Assets
2.94%
Financial Health
Current Ratio
14.70
Debt to Equity
0.00
Beta
-0.08
Per Share Data
EPS (TTM)
₹5.24
Book Value per Share
₹164.34
Revenue per Share
₹16.96
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
tainwalchm | 2.1B | 42.86 | 1.37 | 3.20% | 43.72% | 0.00 |
Asian Paints | 2.4T | 66.38 | 12.32 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.6T | 72.14 | 16.07 | 20.85% | 16.16% | 4.56 |
Balaji Amines | 49.8B | 32.71 | 2.70 | 7.80% | 11.11% | 0.55 |
Camlin Fine Sciences | 46.0B | 85.51 | 5.10 | 5.71% | -8.34% | 77.88 |
Grauer & Weil | 43.1B | 27.36 | 4.58 | 18.02% | 13.85% | 1.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.